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Objectives: This study was undertaken to determine outcome and durability of internal carotid artery bypass grafting with
saphenous vein.
Methods: Data for 50 patients undergoing serial clinical and ultrasound surveillance were collected prospectively and
analyzed retrospectively.
Results: Bypass grafting was performed in 50 patients between 1995 and 2002, the commonest reasons being excessive
endarterectomy zone thinning or penetrating atheroma (n  22), severe internal carotid artery coiling above the
endarterectomy zone (n 14), and patch infection (n 5). Perioperative mortality was 2%, and death and stroke rate was
6%. Perioperative complications were associated with complex cardiovascular events, including hemorrhage after
prosthetic patch infection, on-table thrombosis after endarterectomy, and synchronous carotid artery–cardiac recon-
struction. One patient had a late ipsilateral stroke (10 months; normal scan). Cumulative stroke-free survival at 3 years
(including operative events) was 91%. Cumulative freedom from recurrent stenosis greater than 70% or occlusion was 86%
at 1 year and 83% at 3 years. Severe recurrent stenosis or occlusion developed in 7 patients, within 9 months of surgery
in 6 patients and with 18 months in 1 patient. Angioplasty was performed without complication (no protection device,
no stent) in 5 patients, 3 of whom required repeat angioplasty on at least one further occasion.
Conclusions: In common with venous conduits elsewhere, carotid artery bypass grafting with saphenous vein is associated
with a high incidence of early graft stenosis. The long-term stroke risk, however, is low. Carotid artery bypass grafting is
a safe and durable alternative when endarterectomy would prove hazardous or inadvisable, but regular surveillance is
necessary. (J Vasc Surg 2003;38:1025-30.)
In almost every location other than the carotid bifurca-
tion, bypass grafting with autologous vein or prosthetic
material has replaced endarterectomy for treatment of ath-
erosclerotic arterial disease. However, in a number of situ-
ations, eg, excessive wall thinning after endarterectomy,
prosthetic patch infection, and trauma, reliance on endar-
terectomy may be either inadvisable or hazardous. It is
therefore surprising that few vascular textbooks even de-
scribe the procedure or its outcomes, concentrating solely
on carotid endarterectomy (CEA) and its various modifica-
tions. The purpose of the current study was to evaluate
early and long-term durability of carotid artery bypass
grafting, with particular reference to risks for late stroke and
rates of recurrent stenosis and occlusion.
MATERIAL AND METHODS
A retrospective analysis of prospectively collected data
was undertaken on outcome of 50 patients undergoing
carotid artery bypass grafting between January 1, 1995, and
December 31, 2002. This represents about 4% of total
carotid artery procedures undertaken by the unit during
this period.
Operative procedure. With the exception of treat-
ment of an infected prosthetic patch in 5 patients, the
necessity of carotid artery bypass grafting was not antici-
pated in any patient before surgery; all were scheduled to
undergo routine CEA. When the decision to perform a
bypass procedure was made, saphenous vein was harvested
from the groin, reversed, and placed over the distal limb of
a Pruitt-Inahara shunt (Ideas for Medicine, St Petersburg,
Fla) (Fig 1). The distal anastomosis was completed with
end-to-end anastomosis of the spatulated ends of the inter-
nal carotid artery (ICA) and saphenous vein, with inter-
rupted 6:0 Prolene suture (Ethicon, Edinburgh, Scotland).
The proximal anastomosis was fashioned according to sur-
geon preference. Three methods were used during this
study (Fig 2). In the first, the distal carotid stump was
closed off and the vein graft was anastomosed end-to-side
to the more proximal common carotid artery (CCA). The
second option was to anastomose a tapered venous collar
around the transected CCA, which was then anastomosed
to the vein graft. The rationale was that the vein collar
enabled the diameter to taper from the larger CCA to the
smaller caliber vein graft, and its flexibility enabled the
shunt to be retained for as long as possible. In the third, and
most common preference, the bifurcation was recon-
structed with a long end-to-side anastomosis to preserve
flow through the external carotid artery.
Postoperative assessment. Patients were usually dis-
charged on day 3. All survivors were reviewed at 30 days,
and neurologic status was checked. Any new focal neuro-
logic deficit lasting longer than 24 hours within 30 days of
surgery was classified as stroke, and severity was scored
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according to the Oxfordshire Handicap Scale (OHS) at 30
days. Nondisabling stroke was scored as 0 to 2, and dis-
abling stroke as 3 to 5.1
Wherever possible, patients were serially followed up in
the graft surveillance clinic with clinical examination and
duplex ultrasound (US) scanning at 1, 3, 6, and 12 months
and every 6 months thereafter. Median follow-up was 48
months (range, 1-78 months). Three patients from centers
outside Leicester were lost to follow-up after 30 days. All
late strokes were documented, as was recurrent stenosis
greater than 70% or occlusion within the vein graft.
Statistical analysis. Cumulative statistics, ie, survival,
stroke-free survival, and freedom from stenosis 70% or
occlusion, were calculated with the SPSS package (SPSS,
Chicago, Ill). All operative events were included in each life
table analysis.
RESULTS
Indications for vein bypass grafting. Carotid endar-
terectomy remains the procedure of choice in patients with
atherosclerotic carotid artery disease. Fifty patients (4% of
overall carotid artery procedures) underwent carotid vein
bypass grafting. The commonest reasons for performing
the procedure were concerns about excessive thinning of
the arterial wall after endarterectomy or deep penetrating
atheroma into the adventitia (n  22), presence of severe
kinking or coiling immediately above the endarterecto-
mized ICA (n  14), and treatment of prosthetic patch
infection (n  5) (Table I). Two patients had dilated or
aneurysmal ICA segments in association with symptomatic
atherosclerotic stenosis. One patient had on-table carotid
thrombosis, recognized intraoperatively at transcranial
Doppler US scanning (TCD), and bypass grafting was
performed. In one patient a high rate of on-table emboli-
zation was noted at TCD, which was unresponsive to either
intravenous dextran-40 or heparin therapy. The endarter-
ectomy zone was reopened, thrombus was retrieved from
an otherwise normal looking endarterectomy zone, and
bypass grafting was performed.
Two patients had suspected mycotic aneurysm or pri-
mary plaque infection, confirmed at microbiology in one2.
In one patient, the surgeon had difficulty securing a smooth
Fig 1. Vein bypass grafting is performed by first placing a segment
of reversed groin saphenous vein over the distal limb of a Pruitt-
Inahara shunt. The shunt is then reinserted into the distal internal
carotid artery. The shunt acts as a conduit for continued cerebral
perfusion as well as a stent to aid in distal reconstruction. The blue
sling is around the distal common carotid artery, and the red sling
is around the hypoglossal nerve.
Fig 2. Three methods for performing proximal anastomosis after
distal anastomosis has been completed. A, Origin of internal
carotid artery (ICA) is oversewn, and graft is implanted end-to-
side onto distal common carotid artery (CCA). ECA, External
carotid artery. B, Origin of external carotid artery (ECA) is over-
sewn, Miller vein collar is anastomosed to distal common carotid
artery (CCA), and reversed vein graft is interposed between collar
and distal internal carotid artery (ICA). C, Bifurcation is recon-
structed by anastomosing opened proximal graft onto endarterec-
tomy zone. Heel of opened graft is anastomosed to origin of distal
external carotid artery (ECA). ICA, Internal carotid artery; CCA,
common carotid artery.
Table I. Reasons for performing carotid artery bypass
grafting
No. of patients (N  50)
Thinned endarterectomy zone or
penetrating atheroma
22
Distal internal carotid artery coiled or
kinked
14
Prosthetic patch infection 5
Atherosclerosis and marked vessel
ectasia
2
On-table carotid thrombosis 1
Profuse on-table embolization 1
Postoperative thrombosis (false
aneurysm)
1
“Mycotic” aneurysm 1
Suspected “mycotic” aneurysm 1
Distal intimal dissection after
endarterectomy
1
Mobile plaque after angioplasty and
stenting
1
JOURNAL OF VASCULAR SURGERY
November 20031026 Lauder et al
distal intimal step in a patient with high carotid artery
disease. In 2 patients complications developed after CEA
and carotid artery angioplasty, respectively. The first patient
underwent CEA, in which the operating surgeon had some
difficulty inserting the distal shunt limb. Eight hours post-
operatively, rapid-onset hemiplegia developed, and the pa-
tient was returned to the operating room within 45 minutes
of onset. An acute distal dissection with false aneurysm
formation was encountered with secondary ICA thrombo-
sis. Thrombectomy was performed, and a shunt was in-
serted in the true lumen. Fifteen hours after carotid artery
bypass grafting the patient had full neurologic recovery, as
assessed by the neurology service. The other patient had
previously undergone CEA and had severe recurrent steno-
sis. This was treated with angioplasty and stenting, after
which hemiparesis developed. Duplex US scanning re-
vealed a patent ICA with mobile plaque and thrombus
protruding through the stent interstices. At emergency
repeat exploration the duplex US scanning findings were
confirmed, and vein bypass grafting was performed. The
patient had rapid neurologic recovery, with no evidence of
residual neurologic deficit at 24 hours.
Perioperative complications. Within 30 days of sur-
gery, 1 patient died and 2 patients had stroke. One stroke
was disabling. The single death, due to cardiac failure, was
in a patient undergoing CEA (symptomatic 90% ICA ste-
nosis) combined with coronary artery bypass grafting and
aortic valve replacement.
The disabling stroke (OHS 4 at 30 days) occurred in a
patient who had undergone uneventful CEA 7 weeks pre-
viously. This patient had massive neck hemorrhage. The
original procedure involved dissection to the level of the
styloid process, and it proved extremely difficult to insert a
shunt in the presence of such severe bleeding. Because the
patient had poor collateral circulation (mean middle cere-
bral artery blood flow velocity, 6 cm/s at TCD during
carotid clamping at the original procedure), strenuous at-
tempts were made to perform vein bypass grafting. The
patient awoke with dense hemiplegia. However, significant
recovery ensued, with vein graft patency confirmed with
duplex US scanning at 30 days, and the patient had re-
sumed an independent lifestyle by 6 months.
The nondisabling stroke (OHS 1 at 30 days) occurred
in the patient with thrombosis of the original endarterec-
tomy zone diagnosed on-table with TCD before neck
closure. Reversed vein bypass grafting was performed. On
recovery from anaesthesia the patient had evidence of dys-
phasic stroke but no hemisensory or motor signs.
Long-term outcome. No surviving patient had any
US evidence of recurrent stenosis greater than 70% or
occlusion at 30 days. With the exception of the 1 patient
who died and the 3 patients lost-to follow up after 30 days,
46 patients entered the surveillance program. Median fol-
low-up was 48 months (range, 1-78 months).
Cumulative survival was 96% at 1 year, 90% at 3 years, and
79% at 5 years (Table II). No late deaths followed either stroke
or graft-related complications. Cumulative freedom from
stroke, including operative events, was 91% at 1, 3, and 5 years
(Table II). Only one patient had late stroke, ie, ipsilateral
ischemic stroke at 10 months, with a normal graft scan.
In 7 patients recurrent stenosis greater than 70% or
occlusion developed during follow-up (Fig 3; Table III).
Cumulative freedom from recurrent stenosis greater than
70% or occlusion was 86% at 1 year, 83% at 3 years, and 83%
at 5 years (Table II). Of the 6 patients with severe recurrent
stenosis, the location was the proximal anastomosis, the
mid-zone of the grafts, and the distal anastomosis in 2
patients each. There was no relationship between mode of
proximal anastomosis and location of recurrent stenosis.
Five of the seven patients with recurrent stenosis had no
symptoms, while two patients had transient ischemic at-
tacks (TIA), with multiple episodes in one patient. Most
recurrent stenoses (n  5) were treated with angioplasty
(no protection device, no stent), without neurologic com-
plication (Table III). However, in 3 of these patients repeat
angioplasty was necessary on one (n  2) or two (n  1)
further occasions during follow-up (Table III, patients 1, 3,
and 7). Note, however, that these second recurrent steno-
ses did not develop until 31, 31, and 19 months, respec-
tively, after the first angioplasty. The patient with multiple
TIA (patient 5) underwent repeat exploration and vein
patch angioplasty. At operation, thrombus was removed
from a valve cusp. Vein graft occlusion developed in only 1
patient in this series (patient 6). No abnormality was dem-
onstrated on the 3-month scan, but at 6-month follow-up
asymptomatic graft occlusion was noted.
All significant recurrent stenoses occurred within 9
months in 6 patients and within 18 months in 1 patient. For
example, stenosis was detected 3 months after bypass graft-
ing in a patient with a normal surveillance scan at 30 days
(Fig 3; Table III, patient 1).
Table II. Percent cumulative survival, stroke-free survival, and freedom from recurrent stenosis
Variable
Follow-up interval
30 d 1 y 2 y 3 y 4 y 5 y
% Survival* 98 (50) 96 (44) 93 (37) 90 (34) 87 (31) 79 (28)
% Stroke-free survival* 94 (50) 91 (42) 91 (35) 91 (32) 91 (29) 91 (26)
% Freedom from 70% recurrent stenosis or occlusion 100 (50) 86 (44) 83 (31) 83 (27) 83 (23) 83 (16)
Numbers in parentheses represent number of patients entering stated follow-up interval.
*Operative deaths included in all cumulative analyses.
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DISCUSSION
CEA remains the current standard for treating severe,
atherosclerotic carotid artery disease. However, surpris-
ingly few studies have evaluated the long-term results of
carotid bypass grafting,3-9 which is interesting because
bypass grafting has largely replaced endarterectomy in vir-
tually every other anatomic location. The reasons for the
preference for CEA probably are related to the relative
simplicity of performing CEA; level I studies that have
confirmed the benefit of CEA over best medical therapy;
awareness that vein bypass grafts elsewhere in the body are
prone to stenosis formation; and an understandable prefer-
ence to retain groin saphenous vein for use in other cardio-
vascular reconstruction procedures, eg, infrainguinal by-
pass or cardiac bypass procedures.
However, in a number of situations carotid artery by-
pass grafting is either preferred or unavoidable. Such situ-
ations include prosthetic patch infection, primary carotid
artery infection, excessive coiling or ICA kinking in patients
undergoing CEA, carotid aneurysm, complex carotid body
tumor or paraganglionoma, trauma, and, in selected pa-
tients, rare nonatheromatous disorders, including dissec-
tion, fibromuscular dysplasia, radiation arteritis, giant cell
arteritis, and Takayasu arteritis. Many of these diseases were
represented in the current study, but the single commonest
reason for performing bypass grafting in Leicester was
excessive thinning of the endarterectomy zone or atheroma
penetrating the adventitia. It is, however, accepted that
“endarterectomy zone thinning” is a largely subjective
diagnosis, and inevitably depends on individual surgical
judgment. That postoperative false aneurysm formation
can fatally complicate excessive endarterectomy zone thin-
ning is amply demonstrated in Fig 4. This patient, who
underwent CEA in the unit several years before the current
study was undertaken, had a fatal thrombotic stroke 12
hours after seemingly uncomplicated CEA, secondary to
false aneurysm formation through an extremely thinned
posterior wall of the endarterectomy zone. This particular
case was probably responsible for some surgeons in the unit
adopting a lower threshold for performing vein bypass
grafting than that accepted by other surgeons. More re-
cently, however, there has been an increasing trend toward
using eversion placation, rather than bypass grafting, in
patients with a thinned and redundant endarterectomy.
Accordingly, bypass grafting is now considered only in the
rare patient with excessive posterior wall thinning but no
redundancy.
Fig 3. Severe vein graft recurrent stenosis 3 months after surgery.
Surveillance imaging at 4 weeks showed no graft abnormality.
When repeated at 3 months, there was extensive narrowing of most
of the vein graft, which was successfully treated with angioplasty.
Fig 4. False aneurysm formation through thinned endarterec-
tomy zone 12 hours after endarterectomy, which predisposed to
fatal carotid thrombosis. A, Distal intimal step with corrugation
caused by false aneurysm formation. B, False aneurysm formation
within endarterectomy zone. C, Proximal intimal step. ICA, In-
ternal carotid artery; CCA, common carotid artery; ECA, external
carotid artery.
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Having accepted that bypass grafting may occasionally
be necessary (less than 4% of all carotid reconstruction
procedures in Leicester), is there any evidence that pros-
thetic or venous conduits are preferred, and what are the
long-term results? To date, no randomized trial has com-
pared vein with prosthetic material, usually polytetrafluor-
ethylene (PTFE).3-6 We prefer to use vein, because of its
superior handling and resistance to infection, but recognize
that other centers have reported excellent results with
PTFE.3-6
In the current series, the operative risk for death or
stroke was 6%. With the exception of the series reported by
Branchereau et al,7 this is higher than that in most of the
other published studies of bypass grafting, which has
ranged from 0% to 4%,3,5,7-9 but is comparable with the
results of international trials on CEA. However, the 1
patient who died and the 2 patients with stroke in the
operative period in the current study had complex condi-
tions, ie, hemorrhage after patch infection, on-table carotid
thrombosis, and combined cardiac and carotid artery sur-
gery, and are therefore not strictly comparable with patients
in most published series on bypass grafting or CEA.
Two observations, one positive and one negative, are
apparent from the current study findings. On the positive
side, and in common with the experience of most other
centers, successfully performed bypass grafting was associ-
ated with low (0%-3%) risk for long-term stroke.3-5,7-9 In
the Leicester series, only one late ipsilateral stroke was
noted (normal graft scan). However, on the negative side,
in the Leicester study it was observed that carotid vein
grafts were associated with a high rate of early recurrent
stenosis, especially within the first 9 months. Freedom from
recurrent stenosis greater than 70% or occlusion was 92% at
6 months, and decreased to 86% at 12 months and 83% at
24 months. This is not only higher than observed in a large
contemporary series of patients undergoing CEA in our
unit (see below), but was higher than in any other series
reporting recurrent stenosis rate after carotid bypass graft-
ing, eg, 0%,3 2%,8,9 5%,7 8%,5 and 11%4. This rate is,
however, comparable with primary patency rates after vein
bypass grafting performed elsewhere in the body.
Of the 7 patients with recurrent stenosis greater than
70% or occlusion, only 1, with asymptomatic occlusion,
received conservative treatment. The others, including 2
patients with TIA, underwent either carotid angioplasty (n
 5) or surgical repeat exploration (n  1). Percutaneous
transluminal angioplasty was the preferred option, and
averted the potential risks associated with repeated carotid
artery surgery, eg, increased risk for cranial nerve injury or
stroke. Of interest, in 3 of the 5 patients undergoing
percutaneous transluminal angioplasty further stenosis de-
veloped, requiring additional angioplasty on one or more
occasions. However, none of the three secondary recurrent
stenoses developed until at least 19 months after the first
angioplasty. The policy for treating asymptomatic severe
carotid bypass graft stenosis with angioplasty was based on
the unit’s preexisting protocol for infrainguinal vein graft
surveillance. No randomized trial data exist for guiding
management of severe graft stenosis, and it was generally
believed that stenosis developing within carotid vein grafts
was probably more prevalent and aggressive than after
traditional CEA. No parallel 5-year data are available for
patterns of recurrent disease in patients who have under-
gone CEA, but an internal audit from the unit shows that
3-year freedom from stenosis greater than 70% or occlusion
is 95% (unpublished data), compared with 83% in the
current study.
In summary, carotid artery bypass grafting is a safe
and durable alternative in situations when more tradi-
tional forms of reconstruction are deemed either hazard-
ous or inadvisable. Although the long-term stroke risk
was extremely low, vein bypass grafting was associated
with a high incidence of early graft stenosis. CEA re-
mains our first-line treatment for atherosclerotic carotid
artery disease, and vein bypass grafting is reserved for
selected patients. Patients undergoing carotid artery ve-
nous bypass grafting should, however, enter a long-term
surveillance program.
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